ClinicalTrials.Veeva

Menu

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Extended-spectrum Betalactamase
Escherichia Coli
Enterobacteriaceae
Antibiotic Resistance

Treatments

Other: ESBL

Study type

Observational

Funder types

Other

Identifiers

NCT02367339
CHU-0224

Details and patient eligibility

About

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Full description

Prospective epidemiological study with voluntary non-medical staff member (i.e. nurses and nursing assistants) and medical staff in two French ICUs.

Assessment of self-reported risk factors for MDR-bacteria colonization. Self-performed rectal swab with isolation of ESBL-producting Enterobacteriaceae, identification of bacterial species and antibiotic suspectibilities.

Characterization of Escherichia coli ESBL.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • volunteers

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Patrick LACARIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems